International Experiences in Developing the HIV Service Cascade. RESPOND Conference, June 2015 Shirley Ko, Health Advisor, Pact

Similar documents
Understanding the HIV Care Continuum

HIV Surveillance Update

WISCONSIN AIDS/HIV PROGRAM NOTES

HIV Epidemiology in New York State

Metrics for monitoring the cascade of HIV testing, care and treatment services in Asia and the Pacific

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care

Estimates of New HIV Infections in the United States

READINESS ASSESSMENT MOVING TOWARDS A COUNTRY-LED AND -FINANCED HIV RESPONSE FOR KEY POPULATIONS HEALTH POLICY P R O J E C T

REPORTING CHANGES FOR 2014 NYSDOH AIDS INSTITUTE. Changes to Content and Priorities

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010

HIV Continuum of Care Monitoring Framework 2014

Ending the Epidemic in New York State. Federal AIDS Policy Partnership March 4, 2015

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

HIV/AIDS treatment and care in Georgia. Evaluation report September 2014

HIV/AIDS In the Houston Area

Perspective Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold?

Integrated HIV Prevention and Care Plan Guidance, including the Statewide Coordinated Statement of Need, CY

Maryland HIV Plan

West Virginia HIV/AIDS Surveillance Report 2009 Update West Virginia HIV/AIDS Program

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

Effective Integration of STI & HIV Prevention Programs

Poor access to HCV treatment is undermining Universal Access A briefing note to the UNITAID Board

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

Turning the Tide Against HIV and Tuberculosis. Global Fund Investment Guidance for Eastern Europe and Central Asia

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

How To Get Rid Of Hiv

Vietnam Research Situation Analysis on Orphans and Other Vulnerable Children Country Brief

Quality Management Plan

Routine HIV Monitoring

HIV/AIDS Prevention and Care

Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform

CDC s Country Management and Support Initiative

Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011

Georgia HIV/AIDS Surveillance Summary. Data Through December 31, 2010

NATIONAL ADHERENCE GUIDELINES FOR HIV,TB AND NON COMMUNICABLE DISEASES

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

Case Finding for Hepatitis B and Hepatitis C

HIV AND ADOLESCENTS: HIV TESTING AND COUNSELLING, TREATMENT AND CARE FOR ADOLESCENTS LIVING WITH HIV SUMMARY OF KEY FEATURES AND RECOMMENDATIONS

FOREWORD. Member States in 2014 places patients and communities at the heart of the response. Here is an introduction to the End TB Strategy.

The HIV/AIDS Epidemic in California s Latino Population

GARPR Online Reporting Tool

NATIONAL HIV/AIDS STRATEGY IMPLEMENTING THE

Global Health Research Internship 2016 in Boston

Outpatient/Ambulatory Health Services

STOP TELLING US NOT TO SHARE Participatory project design

STOP HIV/AIDS Quarterly Monitoring Report

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action

HIV Therapy Key Clinical Indicator (KCI)

Evaluation of a decade of DFID and World Bank supported HIV and AIDS programmes in Vietnam from 2003 to 2012

UNAIDS AND MÉDECINS SANS FRONTIÈRES 2015 REFERENCE COMMUNITY-BASED ANTI RETROVIRAL THERAPY DELIVERY EXPERIENCES OF MÉDECINS SANS FRONTIÈRES

HIV New Diagnoses, Treatment and Care in the UK 2015 report

STOP HIV/AIDS Core Collaborative Measures Reporting Tool SECTION 1

STRATEGIC PLAN TO ADDRESS HIV IN IOWA

HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE

HIV Services Quality Management Plan San José, CA (Santa Clara County) Transitional Grant Area. January 1 to December 31, 2012

Hepatitis C. Screening, Diagnosis and Linkage to Care

Hepatitis at a national level: government perspectives

Nicaragua Country Report FY14

Correlates of not receiving HIV care among HIV-infected women enrolling in a HRSA SPNS multi-site initiative

Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Georgia

The Botswana Combination Prevention Project (BCPP)

Guidelines for Nurse Led HIV Clinic

HIV/AIDS in the Houston Area

HIV infection in injecting drug users

Building on Success: A National Strategy to Save Lives

FOREWORD. Coordinating Minister for People s Welfare Republic of Indonesia/ Chairperson of the National AIDS Commission.

Hepatitis C. Eliot Godofsky, MD University Hepatitis Center Bradenton, FL

Dave Burrows Director

AN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS

Integrating Viral Hepatitis Counseling and testing in Substance Abuse Programs. By Barbara Rush CAAPP2 The Center For Drug Free Living Inc.

Tuberculosis in Myanmar Progress, Plans and Challenges

Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System

NATIONAL MONITORING AND EVALUATION PLAN OF THE NATIONAL STRATEGIC PLAN

Using data and tools to inform resource allocation for the HIV response. Dr. Sarah Alkenbrack & Dr. Suneeta Sharma Futures Group

Illustrating HIV/AIDS in the United States

Technical guidance note for Global Fund HIV proposals in Round 11

24 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland June 2009

Stigma and Discrimination

CME Article Hiv Disease Surveillance

APRIL 2013 UPDATING THE RYAN WHITE HIV/AIDS PROGRAM FOR A NEW ERA: KEY ISSUES & QUESTIONS FOR THE FUTURE

HIV& AIDS BASIC FACTS. HIV & Drug Use. You are better off knowing if you have HIV. HIV & Sex. What are HIV & AIDS? HIV & Blood Products

Placing Nation on the Path Toward the Elimination of Hepatitis C

ECDC GUIDANCE. HIV testing: increasing uptake and effectiveness in the European Union.

Comprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance

In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs.

Science addressing drugs and HIV: State of the Art. Vienna

HIV prevention and the wider UK population. What HIV prevention work should be directed towards the general population in the UK?

Q&A on methodology on HIV estimates

Beginner's guide to Hepatitis C testing and immunisation against hepatitis A+B in general practice

HIV/AIDS 101 Teens and Young Adults. Chara McGill

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report Sweden

STOP HIV/AIDS Quarterly Monitoring Report

Annual Surveillance Report 2014 Supplement

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

The use of alcohol and drugs and HIV treatment compliance in Brazil

epidemic among vulnerable groups

Kenya Joint TB/HIV Concept Note Development

Transcription:

International Experiences in Developing the HIV Service Cascade RESPOND Conference, June 2015 Shirley Ko, Health Advisor, Pact

HIV Cascade of Care Model that outlines the sequential stages, or continuum, of medical care that PLHIV go through from initial diagnosis to goal of viral suppression For PLHIV to fully benefit from antiretroviral therapy, they must be engaged and retained along the continuum

Where did the cascade originate? Concept borne out of data in the U.S. that showed only 25% of PLHIV had achieved the national HIV/AIDS treatment goal of viral suppression (2011) Cascade showed that patients were lost at each stage Analysis used to identify gaps in services, develop strategies to improve engagement in care, and target resources Led to establishment of the HIV Care Continuum Initiative in the USA (2013) Growing recognition worldwide that failure across the HIV cascade is a major barrier to achieving universal access to ART and viral suppression of sufficient magnitude to control the epidemic

Experience of HIV cascade in Georgia Reference: Chkhartishvili N, Sharvadze L, Chokoshvili O et al. The cascade of care in the Eastern European country of Georgia. HIV Medicine 2014; 16: 62 66 Evaluation of Georgian cascade included all adult (18+ years) HIVinfected patients diagnosed from 1989-2012* Georgian cascade is an important contribution to our understanding of treatment programs in EECA region, where countries typically have similar HIV epidemiology and health systems

HIV Epidemic in Georgia (by transmission categories) Total reported HIV cases Newly reported HIV cases IDU, 49.4% Hetero, 41.6% Undetermin ed, 0.8% Blood transfusion, 0.5% Vertical, 1.8% Male-tomale sex, 5.9%

Georgian HIV response National HIV/AIDS Treatment & Care Program, since 1995 The Global Fund project, since 2004 Universal access to ART treatment, since 2004 Hepatitis C treatment among HIV patients, since 2011 Programs target PWID, MSM, FSW and prisoners One national AIDS and four regional AIDS centers All services are provided free of charge Robust electronic HIV/AIDS health information system

Evolution of ART guidelines CD4 <500 cells/mm 3 CD4 <350 cells/mm 3 ART initiation: CD4 <200 cells/mm 3 CD4 <250 cells/mm 3

Evolution of ART guidelines Regardless of CD4 cell count 2015? 2016? CD4 <500 cells/mm 3 CD4 <350 cells/mm 3 ART initiation: CD4 <200 cells/mm 3 CD4 <250 cells/mm 3

Georgian HIV Cascade 84% 88% 78% 80%

Georgian HIV Cascade 100% 84% 73% 57% 45% 84% 88% 78% 80%

Cascade of Care: 2008-2013

Taking the cascade one step back 49% 41% 36% 28% 23% Georgia 49% 84% 88% 78% 80%

Taking the cascade one step back 51% undiagnosed Low testing coverage: FSW 42%; MSM 34%; IDU 15% Missed opportunities to diagnose HIV in healthcare settings Low coverage with prevention interventions 49% 84% 88% 78% 80%

What does the cascade tell us? Patients diagnosed with HIV infection are successfully engaged in clinical care However, nearly half of estimated HIV-infected individuals remain unaware Significant gap in HIV testing/diagnosis is result of low testing coverage of key populations and missed opportunities to diagnose HIV infection in health care settings Large number of undiagnosed individuals are likely contributing to the majority of new HIV infections Late HIV diagnosis has serious implications for ART success at individual and population levels

Late Diagnosis: Economic Implications National AIDS program expenditures per person-year (excludes costs of ART)

Strengths & Limitations Mature electronic HIV information system provides cross-sectional snapshot of situation at a single point in time However, does not capture longitudinal dynamics (e.g., viral load suppression in a patient can change) Limited comparability of findings - no unified set of indicators for the cascade yet at both national and global levels WHO is developing metrics for monitoring the cascade

Conclusions for Georgia Cascade is a useful tool for visually demonstrating the strengths and identifying gaps in ART delivery programs Significant gaps in HIV testing/diagnosis requires scale-up Reducing the number of persons living with undiagnosed HIV infection + simultaneously enhancing engagement in continuous care will be important for achieving maximum individual and public health benefits of ART

HIV Cascade Toolkit: Vietnam

HIV Cascade Toolkit: Vietnam Developed and published by FHI 360 (2014) Supported by USAID and PEPFAR Builds on WHO s Metrics for Monitoring the Cascade for HIV Testing, Care and Treatment Services in Asia and the Pacific (2014) Practical how-to guide for HIV program implementers government, civil society at national, province levels Outlines steps for generating cascades Adaptable to other contexts/settings

Vietnam HIV Cascade

Use of Cascade Fosters a culture of data use Usefulness is heavily influenced by quality of available data o Routine data quality assurance procedures are important o Use of UIC is helpful for monitoring linkages between services and tracking individuals as they transition from services and locations Consistency in use of core indicators is critical Cascade is important but not the only tool for HIV service planning and quality improvement efforts o Can be used with service mapping, QI monitoring, epidemic modelling, gender/policy/service access assessments

Use of Unique Identifier Codes Cascade without UIC Cascade with UIC

Building a HIV cascade What? Identify the kind of cascade to be used. Where? Determine geographic area of focus or scope. What service area(s) will be emphasized? Who? Identify the population. When? Plot the time period. How? Distinguish presentation format.

Examples of different cascades Stacking cascade bars

Examples of different cascades Stacking cascade bars

Examples of different cascades Stacking cascade bars

Overall Considerations Cascades are a powerful starting point for further understanding the client flow, service delivery, and linkages across preventioncare continuum Interpretation of cascade data is enhanced by triangulation with other sources of data/information HIV program performance is affected by several factors, including quality and content of services; accessibility and acceptability; available resources; referral systems; and structural environment Discussions with stakeholders on cascade can provide further assistance on role of policies, health systems, communities and individuals to address barriers and facilitators to service uptake

Thank you!